UNC Health Media Briefing =- Dr David Wohl on COVID Treatments, Vaccines & Prevention (10/7/20)

Dr. David Wohl answer questions about topics that includede:

• What we know about President Donald Trump's battle with COVID-19.
• How UNC Health medical specialists are using Remdesivir and Dexamethasone as well as experimental treatments to help COVID-19 patients.
• What the reopening of North Carolina means in the battle against the virus.
• Why COVID testing in underserved communities is crucial.
• The latest developments in clinical trials for potential COVID-19 treatments and vaccines.

DR WOHL

Dr. David Wohl helps lead the respiratory diagnostic center at UNC Medical Center in Chapel Hill that tests hundreds of patients a day for COVID-19.
He also oversees testing efforts in Sanford and other underserved communities, and helps treat COVID-19 patients.

He is the principal investigator of a study evaluating several promising treatments for COVID-19. That includes a large, nationwide, NIH-sponsored trial testing hydroxychloroquine and azithromycin to treat patients with COVID-19.

Before the pandemic began, his research focused on serious viral infections including HIV and viral hemorrhagic fevers, such as Ebola and Lassa fever in West Africa.